Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: Sitemap: |
Title | Treatment Option for Certain Types of EGFR+ NSCLC – TAGRISSO® |
Description | WHAT DOES TAGRISSO Learn about TAGRISSO® (osimertinib), a targeted treatment option for people with certain types of EGFR+ non-small cell lung cancer (NSCLC). Talk to your doctor to see if TAGRISSO is right for |
Keywords | N/A |
WebSite | tagrisso.com |
Host IP | 13.249.93.29 |
Location | United States |
Site | Rank |
US$91,296,724
Last updated: 2023-04-28 17:57:32
tagrisso.com has Semrush global rank of 115,933. tagrisso.com has an estimated worth of US$ 91,296,724, based on its estimated Ads revenue. tagrisso.com receives approximately 10,534,238 unique visitors each day. Its web server is located in United States, with IP address 13.249.93.29. According to SiteAdvisor, tagrisso.com is safe to visit. |
Purchase/Sale Value | US$91,296,724 |
Daily Ads Revenue | US$84,274 |
Monthly Ads Revenue | US$2,528,217 |
Yearly Ads Revenue | US$30,338,604 |
Daily Unique Visitors | 702,283 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
tagrisso.com. | A | 299 | IP: 13.249.93.29 |
tagrisso.com. | A | 299 | IP: 13.249.93.111 |
tagrisso.com. | A | 299 | IP: 13.249.93.97 |
tagrisso.com. | A | 299 | IP: 13.249.93.85 |
tagrisso.com. | NS | 86400 | NS Record: ns-98.awsdns-12.com. |
tagrisso.com. | NS | 86400 | NS Record: ns-1077.awsdns-06.org. |
tagrisso.com. | NS | 86400 | NS Record: ns-1818.awsdns-35.co.uk. |
tagrisso.com. | NS | 86400 | NS Record: ns-720.awsdns-26.net. |
tagrisso.com. | MX | 14400 | MX Record: 10 custmx.cscdns.net. |
tagrisso.com. | TXT | 300 | TXT Record: facebook-domain-verification=v2k1v9sdq4c9tmdl6wfbdincj4q3m4 |
Important Safety Information Prescribing Information For Healthcare Professionals Sign Up for Support Registration Successful... null you have successfully logged registered and logged in For certain patients with EGFR+ NSCLC after surgery or metastatic EGFR+ NSCLC For people with certain types of EGFR+ non-small cell lung cancer (NSCLC), TAGRISSO is a targeted treatment option. Could TAGRISSO be right for your type of lung cancer? WHAT DOES TAGRISSO TREAT? EGFR+ NSCLC following tumor removal by surgery (adjuvant) EGFR+ NSCLC that has spread to other parts of the body (metastatic) EGFR+ NSCLC following tumor removal by surgery (adjuvant) Learn more EGFR+ NSCLC that has spread to other parts of the body (metastatic) Learn more EGFR means epidermal growth factor receptor. Important Safety Information TAGRISSO may cause serious side effects, including: lung problems. TAGRISSO may cause lung problems that may lead to death. Symptoms may be similar to symptoms from lung cancer. Tell your |
HTTP/1.1 403 Forbidden Server: CloudFront Date: Thu, 21 Oct 2021 18:03:58 GMT Content-Type: text/html Content-Length: 919 Connection: keep-alive X-Cache: Error from cloudfront Via: 1.1 16b6be5a931c8f1a8986fa25ce120864.cloudfront.net (CloudFront) X-Amz-Cf-Pop: ORD52-C1 X-Amz-Cf-Id: RXUHH3BwsLiChsLxFAr82I8KEn_866n_uJsUTWdSlhp01vcEoXLI0g== |
Domain Name: TAGRISSO.COM Registry Domain ID: 1922954420_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-04-20T05:11:15Z Creation Date: 2015-04-24T18:14:28Z Registry Expiry Date: 2022-04-24T18:14:28Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-1077.AWSDNS-06.ORG Name Server: NS-1818.AWSDNS-35.CO.UK Name Server: NS-720.AWSDNS-26.NET Name Server: NS-98.AWSDNS-12.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-10T13:32:34Z <<< |